tanya dorff, md, on the role of chemotherapy in mcrpc patients who have failed prior therapies
Published 3 years ago • 67 plays • Length 1:23
Download video MP4
Download video MP3
Similar videos
-
1:38
dr. dorff on role of chemotherapy in mcrpc
-
2:18
tanya dorff, md, on how checkpoint inhibitors are being incorporated into mcrpc treatment algorithms
-
0:47
tanya dorff, md, on impressions of the card study investigating the role of cabazitaxel in mcrpc
-
1:10
tanya dorff, md, regarding the role of car-t cell therapy in the management of psca mcrpc
-
30:09
overview: advanced prostate cancer treatments | tanya dorff, md | 2021 pcri conference
-
1:32
tanya dorff, md, explains the design and outcomes of the acis clinical trial
-
13:40
2022 recap: new treatments and approaches in #prostatecancer | #markscholzmd | pcri
-
3:15
prostate cancer costs more than your life
-
11:17
car-t cells: engineered cancer killers
-
1:19
tanya dorff, m.d. on new clinical trial for bladder cancer | #asco21
-
1:10
dr. dorff on current agents for patients with mcrpc
-
57:40
492.tanya dorff, m.d. "the chaarted study of the advantage of early chemothereapy treatment"
-
1:55
meet our doctors: tanya dorff, m.d. | city of hope
-
1:04
dr. tanya dorff on the future of car t cell therapy for prostate cancer | asco22
-
0:23
tanya dorff, md, shares thoughts of the optimal sequence of atezolizumab and sip-t in mcrpc
-
1:03:59
immunotherapy -dr. tanya dorff
-
1:24
dr. dorff discusses the use of parp inhibitors in prostate cancer
-
8:40
additional advances in advanced prostate cancer with tanya dorff, md
-
13:00
what prostate cancer patients need to know about treatment during the covid-19 pandemic
-
0:40
tanya dorff, md, on the future of cellular immunotherapy versus checkpoint inhibition in mpc
-
4:00
importance of genomic testing for patients with metastatic prostate cancer
-
1:08:48
467 tanya dorff, md unique techniques for dealing with prostate cancer, april 26, 2012
Clip.africa.com - Privacy-policy